Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Gösterilen 4 / 8
Aseptic valves face exceptionally high demands within UltraClean and Aseptic processes. You can be assured that they all provide highest quality in terms of hygienic design and sustainability.
GEA'nın yenilikçi CIP konseptleri, kapsamlı yüksek standartları karşılamaktadır. Uzmanlarımız, prosesin her noktasında ürün güvenliğini garanti etmektedir. Her bir iyileştirme işlemi, yerel şartlara ve müşteri gerekliliklerine adapte edilir ve farkedilebilir tasarruflar sağlar.
GEA Hilge offers a versatile range of centrifugal and positive displacement pumps for a wide variety of sensitive applications in the beverage, food and pharmaceutical industries.
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
Bitki odaklı faaliyet gösteren Güney Koreli gıda üreticisi Pulmuone, GEA’nın önüne geleneksel çiğnenebilir soğuk (naengmyeon) erişteye modern bir dokunuş katma zorluğunu getirdiğinde, GEA’nın AR&GE uzmanları bu meydan okumaya hazırdı. Daha önceki yöntemlere göre daha az su ve elektrikle üretilen ve ticari açıdan şu an popüler olan bir ürünün geliştirilmesine yardımcı oldular. Sonuç, aynı zamanda yemeğin geleneksel kökenlerine olduğu kadar Pulmuone’nin sağlık, refah ve sürdürülebilirlik köklerine uygundur.
GEA’nın yenilikçi prosesi, hidro-işlemden geçmiş bitkisel yağ ve sürdürülebilir havacılık yakıtı gibi biyo-yakıtların ön-işleminde bir dönüm noktasını işaret etmektedir. Ağartma işlemini ortadan kaldırmak suretiyle üreticiler, önemli tasarruf potansiyellerinden faydalanmaktadır: %50’nin üstünde daha düşük işletme maliyeti ve %12’ye varan daha az CO2 emisyonu.